Alpha Crest Capital Management LLC Voyager Therapeutics, Inc. Transaction History

Alpha Crest Capital Management LLC

  • $0
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020
SELL
$6.8 - $14.66 $242,080 - $521,896
-35,600 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$12.82 - $16.85 $456,392 - $599,860
35,600 New
35,600 $497,000
Q1 2019

May 10, 2019
SELL
$8.0 - $19.66 $86,400 - $212,328
-10,800 Closed
0 $0
Q4 2018

Feb 11, 2019
BUY
$8.59 - $18.05 $92,772 - $194,940
10,800 New
10,800 $102,000

Others Institutions Holding VYGR

# of Institutions
132
Shares Held
35.1M
Call Options Held
5.6K
Put Options Held
46.2K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $163M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email